GSK2245035
CAS No. 1207629-49-9
GSK2245035( GSK 2245035 | GSK-2245035 )
Catalog No. M10768 CAS No. 1207629-49-9
GSK2245035 is a highly potent, selective TLR7 agonist that selectively induces TFN-α in PBMC assays with pEC50 of 9.3, >2 logs selectivity over TNFα pEC50.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 245 | Get Quote |
|
| 50MG | 1107 | Get Quote |
|
| 100MG | 1476 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK2245035
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK2245035 is a highly potent, selective TLR7 agonist that selectively induces TFN-α in PBMC assays with pEC50 of 9.3, >2 logs selectivity over TNFα pEC50.
-
DescriptionGSK2245035 is a highly potent, selective TLR7 agonist that selectively induces TFN-α in PBMC assays with pEC50 of 9.3, >2 logs selectivity over TNFα pEC50; suppresses Th2 cytokine responses to allergens in human cell cultures, causes local upregulation of TLR7-mediated cytokines (IP-10) in vivo after intranasal administration at very low doses.Asthma Phase 2 Clinical.
-
In Vitro——
-
In VivoAnimal Model:Female BALB/c mice Dosage:0.03, 0.1, 0.3, 1 mg/kg Administration:Intranasally (i.n.); 6 hours Result:Dose-related increases in IFNα levels in serum were detected at doses of 0.3 mg/kg and above at the 2 h time point which had subsided at 6 h.
-
SynonymsGSK 2245035 | GSK-2245035
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorTLR
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number1207629-49-9
-
Formula Weight390.532
-
Molecular FormulaC20H34N6O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (320.09 mM)
-
SMILESCCCC(C)OC1=NC(=C2C(=N1)N(C(=O)N2)CCCCCN3CCCCC3)N
-
Chemical Name(S)-6-amino-2-(pentan-2-yloxy)-9-(5-(piperidin-1-yl)pentyl)-7,9-dihydro-8H-purin-8-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
RS09 2TFA 1449566-36...
RS09 2TFA is a TLR4 agonist.?Promotes NF-κB nuclear translocation and induces inflammatory cytokine secretion in RAW264.7 macrophages in vitro.??It acts as an adjuvant in vivo and enhances X-15 specific antibody serum concentrations.
-
Resatorvid
Resatorvid (TAK-242) is a selective inhibitor of Toll-like receptor 4 (TLR4). Resatorvid inhibits IL-6, TNF-R and NO production (IC50s: 1.3 nM, 1.9 nM, and 1.8 nM).Resatorvid suppresses the production of NO, TNF-α, and IL-6 from LPS-stimulated human peripheral blood mononuclear cells (PBMCs, IC50s: 11-33 nM).
-
BMS-378806
BMS-378806 selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus.
Cart
sales@molnova.com